Genetic Technologies hires new CFO
Genetic Technologies (ASX:GTG) has appointed Eutillio Buccilli as its latest chief financial officer (CFO).
Buccilli has had more than 35 years of senior management experience in the financial services, contracting and recruitment, property and retail industries in both Australia and the USA.
He has previously worked at major companies including Coles Myer, General Electric and Challenger Limited. Through his career, he has accrued financial, corporate governance and commercial experience.
In March, GTG announced the results of a simulation study showing that its BREVAGen breast cancer risk assessment tool is a cost-effective way to direct tamoxifen chemoprevention. The company also entered another settlement and licensing deal as part of its US patent enforcement efforts.
Genetic Technologies (ASX:GTG) shares were trading unchanged at $0.04 as of around 1 pm on Wednesday.
Algae unlocks a more ethical way to grow cells
Researchers have combined a new type of Queensland algae, Chlorella sp. BDH-1, with...
Oral drug shows promise for treating Barth syndrome
An oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome, a rare...
New route into cells found for gene therapy viruses
Scientists have identified a previously unknown gateway into human cells — a receptor...
